A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites.
about
Caffeic acid phenethyl ester (CAPE), derived from a honeybee product propolis, exhibits a diversity of anti-tumor effects in pre-clinical models of human breast cancerThe use of Complementary and Alternative Medicine by cancer patientsHealth food store recommendations: implications for breast cancer patientsAre herbal remedies and dietary supplements safe and effective for breast cancer patients?Gentle Massage Improves Disease- and Treatment-Related Symptoms in Patients with Acute Myelogenous Leukemia.Changes in complementary and alternative medicine use across cancer treatment and relationship to stress, mood, and quality of life.Massage therapy for essential hypertension: a systematic review.Use of multivitamins, folic acid and herbal supplements among breast cancer survivors: the black women's health study.Feasibility of implementing a community-based randomized trial of yoga for women undergoing chemotherapy for breast cancer.The roles of herbal remedies in survival and quality of life among long-term breast cancer survivors--results of a prospective study.Estrogen receptor beta-selective transcriptional activity and recruitment of coregulators by phytoestrogens.Intervention fidelity: aspects of complementary and alternative medicine research.Any difference? Use of a CAM provider among cancer patients, coronary heart disease (CHD) patients and individuals with no cancer/CHD.Breast cancer survivors willingness to participate in an acupuncture clinical trial: a qualitative studyHow many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis.In vitro evaluation of anticancer potentials of lupeol isolated from Elephantopus scaber L. on MCF-7 cell lineUse of complementary/integrative nutritional therapies during cancer treatment: implications in clinical practice.The use of herbal medicines by people with cancer: a cross-sectional surveyEvaluation of effectiveness of herbal medication in cancer care: a review study.Recruitment and early retention of women with advanced breast cancer in a complementary and alternative medicine trial.Why breast cancer patients seek traditional healers.The Use of Complementary and Alternative Medicine among Lebanese Adults: Results from a National SurveyBeliefs and perceptions of women with newly diagnosed breast cancer who refused conventional treatment in favor of alternative therapiesPerioperative herbal supplement use in cancer patients: potential implications and recommendations for presurgical screening.The evolution of mindfulness-based physical interventions in breast cancer survivorsReasons for and characteristics associated with complementary and alternative medicine use among adult cancer patients: a systematic review.Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology studyReasons to Use and Disclose Use of Complementary Medicine Use - An Insight from Cancer Patients.Predictors of complementary and alternative medicine use in cancer care: results of a nationwide multicenter survey in Korea.Complementary and alternative medicine use among women at increased genetic risk of breast and ovarian cancerPredictors of yoga use among patients with breast cancer.Complementary and Alternative Medicine Use among Norwegian Cancer Survivors: Gender-Specific Prevalence and Associations for Use.Lesson from comparison of CAM use by women with female-specific cancers to others: it's time to focus on interaction risks with CAM therapies.The value of acupuncture in cancer care.Discrepant views of Korean medical oncologists and cancer patients on complementary and alternative medicine.Prevalence and predictors of antioxidant supplement use during breast cancer treatment: the Long Island Breast Cancer Study Project.Practices, attitudes, and beliefs associated with complementary and alternative medicine (CAM) use among cancer patients.Prevalence and predictors of complementary therapy use in advanced-stage breast cancer patients.Attitudes and barriers towards participation in an acupuncture trial among breast cancer patients: a survey study.Propolis and its Active Component, Caffeic Acid Phenethyl Ester (CAPE), Modulate Breast Cancer Therapeutic Targets via an Epigenetically Mediated Mechanism of Action
P2860
Q24628786-2465EA31-D13B-400B-98A6-0E04FE47B189Q24683698-0399C83D-B1A4-49B2-9961-A59A774BAFDAQ24802571-5C8C563E-DF73-4841-8AAF-459710724864Q24803098-EC9F77D0-9534-4BB9-9AC1-919D4A457D7AQ30301087-0D85ABC1-E431-4FC2-8B81-35E2027DA90BQ30368095-58BC2D1E-BD88-4950-B4B8-1562475DC7FCQ31170781-BCA458B3-33FD-4921-9D74-BB304DDA537BQ33874307-BA593A63-B2D5-4DC8-A9DC-5FFEF6F6524EQ33905142-4861D25B-B654-4103-B4DC-8809E40F8F8CQ33924599-C1F9EDBF-81E6-4BCD-9C94-1C83B6CDF72CQ33940621-B601390A-8947-4389-91E2-D9A810A52F51Q34023405-C4EBE58A-4122-4D20-8382-904DCA82C1F2Q34125820-B1A3A5F8-666B-4A4F-AA30-CD3DFFAB1B26Q34172706-A6D64040-9475-4620-9D15-258A15603FD3Q34226495-FA3F49FC-5FB8-439C-90D8-AD57629DE0C1Q34432344-31ECD921-3C24-47A1-8237-92B68E326577Q34681066-9862F58D-C61B-4FA3-8A2E-99081DBA225BQ34727333-72F745DE-EA4F-4F11-BFBF-042F3F5EC697Q34959075-5302F0A9-6BD8-45C2-A675-70C244D4AA29Q35108431-F9110540-699A-4D20-A0A1-19C3A8D4FF5EQ35684539-D7EC47A1-24B2-4940-9C3C-D09387011EAFQ35708417-FD5F1E84-1B2B-4ABA-A509-2CABF67E75CFQ35989955-48800F8B-FE78-4BAD-AA81-3433518EA709Q36215507-80612D2B-F947-4D82-B4D7-A57793C3A2E0Q36246750-954FEBD2-14B6-4819-AB3A-95063AE415E9Q36311163-1C4E2E0E-B349-491B-A6A0-B2A8BC822198Q36315926-FD782DD3-6054-4337-ADE2-77E5A7F91A21Q36341712-FE836B74-A299-430A-AF56-9538ED647D7EQ36531132-0B8D54DA-924B-42F4-8621-751DEE0EAF3FQ36667556-E8E6C2C1-B878-4A7C-984F-88C98ACF3FFEQ36692639-55E712C3-292A-4470-A3F2-48B9053C11EAQ36763496-6634D6C4-66B1-4FFD-8406-720E7B9435C5Q37019717-8A26BD7A-26E9-40AC-8CD1-65A197A683A3Q37097842-95529F44-1040-46D8-8C81-E2368658AD57Q37230174-9A7F362C-322C-4346-A678-29D5817C3BF6Q37390895-02C07A0B-47B4-4E71-B03B-108BC8552A1CQ37416421-B2CC6F5E-5546-44EF-8BE5-4D2521BD1770Q37476562-0C4739C0-48BE-48DD-8397-4A840B110F76Q37485874-4A9A6656-AB6E-4F16-9088-661A3550DCD1Q37503537-E1F0E64E-9C0D-4C1B-91CA-6F12EA002FAC
P2860
A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
A comparison of complementary ...... ith other primary tumor sites.
@en
A comparison of complementary ...... ith other primary tumor sites.
@nl
type
label
A comparison of complementary ...... ith other primary tumor sites.
@en
A comparison of complementary ...... ith other primary tumor sites.
@nl
prefLabel
A comparison of complementary ...... ith other primary tumor sites.
@en
A comparison of complementary ...... ith other primary tumor sites.
@nl
P2093
P1476
A comparison of complementary ...... ith other primary tumor sites.
@en
P2093
P304
P356
10.1016/S0002-9610(00)00358-5
P407
P577
2000-05-01T00:00:00Z